(S (NP-SBJ The/DT interleukin/NN 2/CD CD28-responsive/JJ complex/NN) (VP contains/VBZ (NP (NP (NP (QP at/IN least/JJS three/CD) members/NNS) (PP of/IN (NP the/DT NF/NN kappa/NN B/NN family/NN))) :/: (NP-COOD (NP c-Rel/NN) ,/, (NP p50/NN) ,/, and/CC (NP p65/NN)))) ./.)
(S (NP-SBJ (NP Optimal/JJ activation/NN) (PP of/IN (NP T/NN cells/NNS))) (VP requires/VBZ (NP (QP at/IN least/JJS two/CD) signals/NNS)) ./.)
(S-COOD (S (NP-SBJ-55 One/CD signal/NN) (VP can/MD (VP be/VB (VP delivered/VBN (NP *-55/-NONE-) (PP by/IN (NP-LGS the/DT antigen-specific/JJ T-cell/NN receptor/NN)))))) ,/, and/CC (S (NP-SBJ-56 the/DT second/JJ signal/NN) (VP is/VBZ (VP provided/VBN (NP *-56/-NONE-) (PP by/IN (NP-LGS (NP the/DT costimulatory/JJ molecule/NN -LRB-/-LRB- s/NNS -RRB-/-RRB-) (VP delivered/VBN (NP */-NONE-) (PP by/IN (NP-LGS the/DT antigen-presenting/JJ cell/NN)))))))) ./.)
(S-COOD (S (NP-SBJ CD28/NN) (VP is/VBZ (NP-PRD a/DT T-cell/NN surface/NN molecule/NN))) and/CC (S (NP-SBJ-57 (NP stimulation/NN) (PP through/IN (NP this/DT protein/NN))) (VP plays/VBZ (NP an/DT important/JJ role/NN) (PP in/IN (S (NP-SBJ *-57/-NONE-) (VP delivering/VBG (NP the/DT second/JJ activation/NN signal/NN)))))) ./.)
(S (PP In/IN (NP this/DT report/NN)) ,/, (NP-SBJ we/PRP) (VP show/VBP (SBAR that/IN (S (PP in/IN (NP human/JJ peripheral/JJ blood/NN T/NN cells/NNS)) ,/, (NP-SBJ CD28-mediated/JJ signal/NN transduction/NN) (VP involves/VBZ (NP (NP the/DT rel/NN family/NN proteins/NNS) --/: (NP-COOD (NP c-Rel/NN) ,/, (NP p50/NN) ,/, and/CC (NP p65/NN))))))) ./.)
(S-COOD (S (NP-SBJ (NP Treatment/NN) (PP of/IN (NP peripheral/JJ blood/NN T/NN cells/NNS)) (PP with/IN (NP-COOD (NP (NP phorbol/NN 12-myristate/NN 13-acetate/NN) (PRN -LRB-/-LRB- (NP PMA/NN) -RRB-/-RRB-)) and/CC (NP (NP anti-CD28/JJ monoclonal/JJ antibody/NN) (PRN -LRB-/-LRB- (NP mAb/NN) -RRB-/-RRB-))))) (VP results/VBZ (PP in/IN (NP (NP augmentation/NN) (PP of/IN (NP nuclear/JJ (NP-COOD (NP c-Rel/NN) ,/, (NP p50/NN) ,/, and/CC (NP p65/NN)))))))) ,/, and/CC (S (NP-SBJ this/DT augmentation/NN) (VP can/MD (VP occur/VB (PP in/IN the/DT presence/NN of/IN (NP the/DT immunosuppressant/JJ cyclosporin/NN A/NN))))) ./.)
(S (NP-SBJ It/PRP) (VP is/VBZ (ADVP also/RB) (VP shown/VBN (PP in/IN (NP this/DT report/NN)) (SBAR that/IN ,/, (S (PP in/IN response/NN to/TO (NP-COOD (NP PMA\/anti-CD28/JJ mAb/NN) or/CC (NP anti-CD3\/anti-CD28/JJ mAb/NN))) ,/, (NP-SBJ-COOD-58 (NP c-Rel/NN) ,/, (NP p50/NN) ,/, and/CC (NP p65/NN)) (VP are/VBP (VP associated/VBN (NP *-58/-NONE-) (PP with/IN (NP (NP CD28-responsive/JJ element/NN) (ADJP present/JJ (PP in/IN (NP (NP the/DT promoter/NN) (PP of/IN (NP the/DT human/JJ interleukin/NN 2/CD gene/NN))))))))))))) ./.)
(S (NP-SBJ-59 (NP The/DT functional/JJ significance/NN) (PP of/IN (NP (NP c-Rel/NN involvement/NN) (PP in/IN (NP the/DT CD28-responsive/JJ complex/NN))))) (VP is/VBZ (VP demonstrated/VBN (NP *-59/-NONE-) (PP by/IN (NP-LGS (NP transient/JJ transfection/NN analysis/NN) ,/, (SBAR (WHADVP-60 where/WRB) (S (NP-SBJ (NP cotransfection/NN) (PP of/IN (NP c-Rel/NN))) (VP augments/VBZ (NP (NP the/DT level/NN) (PP of/IN (NP (NP expression/NN) (PP of/IN (NP (NP a/DT chloramphenicol/JJ acetyltransferase/NN reporter/NN gene/NN) (VP linked/VBN (NP */-NONE-) (PP to/TO (NP the/DT CD28-responsive/JJ element/NN)))))))) (ADVP *T*-60/-NONE-)))))))) ./.)
